VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $10,000 | -54.5% | 49 | -68.8% | 0.01% | -66.7% |
| Q4 2014 | $22,000 | -46.3% | 157 | -49.8% | 0.02% | -60.0% |
| Q3 2014 | $41,000 | +5.1% | 313 | 0.0% | 0.04% | +7.1% |
| Q2 2014 | $39,000 | -4.9% | 313 | 0.0% | 0.04% | -8.7% |
| Q1 2014 | $41,000 | +10.8% | 313 | -0.9% | 0.05% | +7.0% |
| Q4 2013 | $37,000 | +117.6% | 316 | +90.4% | 0.04% | +104.8% |
| Q3 2013 | $17,000 | +21.4% | 166 | 0.0% | 0.02% | +10.5% |
| Q2 2013 | $14,000 | – | 166 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |